X0304 4 2012-02-22 0 0001100962 ENDO PHARMACEUTICALS HOLDINGS INC ENDP 0001487179 McHugh Julie C/O ENDO PHARMACEUTICALS HOLDINGS INC. 100 ENDO BOULEVARD CHADDS FORD PA 19317 0 1 0 0 Chief Operating Officer 2010 Stock Incentive Plan Restricted Stock Units (RSU) 2012-02-22 4 A 0 16138 A 27946 D 2010 Stock Incentive Plan Performance Shares 2012-02-22 4 A 0 16138 A 31883 D Common Stock, par value $0.01 per share 2012-02-23 4 F 0 1251 34.79 D 2686 D 2010 Stock Incentive Plan Stock Options 34.70 2012-02-22 4 A 0 53131 0.00 A 2022-02-22 Common Stock 53131 53131 D Upon each vesting date, each vested restricted stock unit automatically converts into one (1) share of Endo Pharmaceuticals Holdings Inc. common stock. These restricted stock units (RSUs) are generally exercisable 25% per year on each of February 22, 2013, February 22, 2014, February 22, 2015 and February 22, 2016. Upon vesting, we consider the underlying RSUs to be expired. These securities were granted to Ms. McHugh in consideration of her services as the Chief Operating Officer of Endo Pharmaceuticals Holdings Inc. The performance shares vest upon the Company achieving certain financial targets. Represents target quantity of shares issuable. The exact number of shares issuable will be determined on achievement of certain company performance targets over a cumulative 3-year period, as determined by the Compensation Committee of the Board of Directors of Endo Pharmaceuticals Holdings Inc. The executive can earn between 0% and 200% of the target shares. Twenty-five percent (25%) of Ms. McHugh's February 23, 2011 grant of restricted stock units (RSUs) vested on February 23, 2012. Upon vesting, certain shares are withheld by the issuer to satisfy tax obligations on shares acquired. These shares represent stock withheld by the issuer to satisfy tax withholding obligations on shares acquired upon vesting of restricted stock units. $34.79 represents the average price of the shares sold on February 23, 2012. Representing the right to buy shares of common stock, par value $0.01 per share, of Endo Pharmaceuticals Holdings Inc. These stock options are generally exercisable 25% per year on each of February 22, 2013, February 22, 2014, February 22, 2015 and February 22, 2016. /s/ Caroline B. Manogue, by power of attorney 2012-02-24